Brivaracetam Solution
Product Images NDC 72673-031

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brivaracetam (NDC 72673-031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zhejiang Poly Pharm. Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Brivaracetam 01)

Chemical Structure (Brivaracetam 01)
Chemical structure diagram of brivaracetam, depicting its molecular components and arrangement as represented in the FDA SPL submission for the oral solution dosage form.*
FDA Label Image

Figure 1 (Brivaracetam 02)

Figure 1 (Brivaracetam 02)
A bar chart showing the proportion of patients (%) categorized by reduction in seizure frequency from baseline (%) for placebo and brivaracetam at doses of 50 mg/day, 100 mg/day, and 200 mg/day. The x-axis groups patients by percentage reduction intervals from worse to 75 to <100, while the y-axis indicates the proportion of patients. Four sets of bars represent placebo and the three brivaracetam dosages.*
FDA Label Image

Principal Display Panel (10 mg/mL Bottle Carton)

Principal Display Panel (10 mg/mL Bottle Carton)
Packaging label for Brivaracetam Oral Solution 10 mg/mL by Zhejiang Poly Pharm. Co., Ltd. The label is for a 300 mL oral solution prescription drug. Key information includes dosage strength, manufacturer details, NDC 72673-031-10, pharmacist instructions to dispense accompanying medication guide, and storage and usage directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.